What are the benefits and harms of belimumab for patients with systemic lupus erythematosus?: A Cochrane Review summary with commentary

Int J Rheum Dis. 2021 Oct;24(10):1331-1333. doi: 10.1111/1756-185X.14214. Epub 2021 Sep 14.
No abstract available

Keywords: Cochrane Review summary; belimumab; systemic lupus erythematosus.

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized*
  • Humans
  • Lupus Erythematosus, Systemic*

Substances

  • Antibodies, Monoclonal, Humanized
  • belimumab